Loading clinical trials...
Loading clinical trials...
We hypothesize that midodrine treatment of refractory hypotension in patients otherwise ready for discharge from the ICU shortens duration of receiving IV vasopressors and SICU length of stay without ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Massachusetts General Hospital
Collaborators
NCT07188350 · Mechanical Ventilation, Critical Illness, and more
NCT06189924 · Acute Respiratory Failure, Critical Illness
NCT06667999 · Intensive Care Patients, Intensive Care Unit Patients, and more
NCT07481851 · Hypotension, Urologic Neoplasms, and more
NCT07298720 · Critical Illness
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Sir Charles Gairdner Hospital
Nedlands, Western Australia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions